Ultralife (ULBI) Revenue (2010 - 2026)

Ultralife has reported Revenue for 17 years, with the latest figure at $47.4 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 6.5% year-over-year to $47.4 million; the trailing twelve-month figure through Mar 2026 stood at $187.9 million (up 8.42% YoY), and the FY2025 full-year result was $191.2 million, up 16.24% from the prior year.
• Revenue for Q1 2026 stood at $47.4 million, down from $48.5 million in the prior quarter.
• The five-year high for Revenue was $50.7 million in Q1 2025, with the low at $30.4 million in Q1 2022.
• Average Revenue over 5 years is $40.8 million, with a median of $42.7 million recorded in 2023.
• Year-over-year, Revenue jumped 52.72% in 2022 and decreased 9.61% in 2024.
• Tracing ULBI's Revenue over 5 years: stood at $36.1 million in 2022, then climbed by 23.38% to $44.5 million in 2023, then retreated by 1.56% to $43.9 million in 2024, then increased by 10.56% to $48.5 million in 2025, then slipped by 2.14% to $47.4 million in 2026.
• The last three Revenue figures came in at $47.4 million (Q1 2026), $48.5 million (Q4 2025), and $43.4 million (Q3 2025), per Business Quant data.

Peer Comparison